PATEL DINESH V PH D (President and CEO) sold 12.5% of their position (75K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $7.51M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/12/2026ACC: 0001104659-26-059591
DirectorOfficer· President and CEO
Since Jul 2018
-75K
Net shares
Net seller
$7.51M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
75K acquired · 150K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75K
Price / share
$21.58
Trade value
$1.62M
% of position
14.3%
5/12/2026
523.48K→598.48K
Common Stock
Direct
Shares
−75K
Price / share
$100.12
Trade value
$7.51M
% of position
12.5%
5/12/2026
598.48K→523.48K
Total
Net shares
+0.00
Net value
-$5.89M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2026 | M · Option Exercise | +75K | $21.58 | $1.62M | 14.3% | 523.48K | 598.48K |
| Common Stock Direct | 5/12/2026 | S · Sale | −75K | $100.12 | $7.51M | 12.5% | 598.48K | 523.48K |
| Total | +0.00 | -$5.89M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
−75K
Strike price
21.58
Held after
225K
Exercisable
—
5/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock75K shares | 5/12/2026 | M · Option Exercise | −75K | 21.58 | — | 225K |